Incyte CORP Form 4 insider transactions

NASDAQ
Director Paul J. Clancy reports acquisition of Incyte Corp stock and options, including 2,830 shares of common stock and options to purchase 12,517 shares.
NASDAQ
Principal Accounting Officer Tray Thomas sold 1,093 shares of Incyte Corp common stock at a price of $58.91 on June 6, 2024.
NASDAQ
Baker Bros. Advisors LP reports changes in beneficial ownership of Incyte Corp stock due to the exercise of stock options by Julian C. Baker, a director of Incyte, with the resulting shares allocated to affiliated funds.
NASDAQ
Director Paul J. Clancy acquired 403 shares of Incyte Corp common stock at $56.97 per share on March 28, 2024, and holds 15,785 shares following the transaction.
NASDAQ
Director Edmund Harrigan acquired 413 shares of Incyte Corp common stock at $56.97 per share under a Rule 10b5-1 plan, while holding 13,115 shares after the transaction.
NASDAQ
Baker Bros. Advisors LP reports changes in beneficial ownership of Incyte Corp stock due to director retainer fees and indirect ownership interests.
NASDAQ
EVP Matteo Trotta reports acquisition of restricted stock units and stock options in Incyte Corp.